Vivjoa (oteseconazole) is a prescription antifungal medication used to prevent recurrent vulvovaginal candidiasis (RVVC) in females with a history of RVVC who are not of reproductive potential. RVVC is a condition in which women experience four or more episodes of vulvovaginal candidiasis (VVC) within a 12-month period.